These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 13744810)

  • 1. The hypocholesterolemic effect of triparanol (MER-29) in man.
    RUSKIN A
    Arch Intern Med; 1960 Dec; 106():803-8. PubMed ID: 13744810
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trials in atherosclerotics with Triparanol (MER-29) diminishing the biosynthesis of cholesterol].
    KELLER L; GERGELY J
    Z Gesamte Inn Med; 1962 Feb; 17():183-6. PubMed ID: 14454950
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences with Triparanol, a drug inhibiting cholesterol biosynthesis, in atherosclerotic patients].
    KELLER L; GERGELY J
    Orv Hetil; 1962 Apr; 103():690-2. PubMed ID: 14454951
    [No Abstract]   [Full Text] [Related]  

  • 4. Control of serum lipids by diet and triparanol (MER 29).
    WILLIAMS GE; GADDIE R; SINGH SP
    J Atheroscler Res; 1962; 2():96-103. PubMed ID: 14007156
    [No Abstract]   [Full Text] [Related]  

  • 5. Decholesterolizing measures with clinical observations on triparanol (MER-29).
    COOPER EE
    Tex State J Med; 1960 Oct; 56():775-9. PubMed ID: 13695305
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of triparanol and sodium dextrothyroxine to lower serum cholesterol.
    GOYETTE EM; SAAD A
    Angiology; 1962 Feb; 13():88-93. PubMed ID: 13900898
    [No Abstract]   [Full Text] [Related]  

  • 7. Observations on the effect of triparanol (MER-29) on the serum cholesterol of selected human subjects.
    ROSENMAN RH; FRIEDMAN M
    Prog Cardiovasc Dis; 1960 May; 2():605-11. PubMed ID: 14439028
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of MER-29 (triparanol) on serum cholesterol, cholesterol esters and liver enzymes.
    RUSKIN A; RUSKIN B
    Prog Cardiovasc Dis; 1960 May; 2():624-30. PubMed ID: 14440267
    [No Abstract]   [Full Text] [Related]  

  • 9. [The hypocholesterolemic action of triparanol].
    HODARA M
    Sem Hop; 1962 Jan; 38():267-8. PubMed ID: 13907933
    [No Abstract]   [Full Text] [Related]  

  • 10. A brief experience with triparanol (MER-29).
    STRAIGHT WM; LAHUIS NC
    J Fla Med Assoc; 1961 Oct; 48():341-5. PubMed ID: 13917595
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinical study of triparanol (MER-29).
    LISAN P; OAKS W; MOYER JH
    Am J Cardiol; 1960 Aug; 6():246-51. PubMed ID: 14417444
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypercholesterolemia and atherosclerosis. First results obtained in our country with triparanol].
    CAMPAGNOLI M; LOPEZ GIL AL; PRESS L; RUDA M
    Dia Med; 1961 Aug; 33():1806-8. PubMed ID: 13690165
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic significance of triparanol (MER-29).
    LISAN P
    Prog Cardiovasc Dis; 1960 May; 2():618-21. PubMed ID: 14417446
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronary atherosclerosis status of MER-29 (triparanol).
    CORCORAN AC
    Am Heart J; 1961 Apr; 61():431-5. PubMed ID: 13695464
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of triparanol (MER-29) in subjects with and without coronary artery disease.
    HOLLANDER W; CHOBANIAN AV; WILKINS RW
    JAMA; 1960 Sep; 174():5-12. PubMed ID: 13852511
    [No Abstract]   [Full Text] [Related]  

  • 16. The cholesterol lowering effects of triparanol (MER-29) in subjects with and without coronary artery disease.
    HOLLANDER W; CHOBANIAN AV; WILKINS RW
    Prog Cardiovasc Dis; 1960 May; 2():637-44. PubMed ID: 13852510
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies of serum desmosterol levels in hypercholesteremic subjects treated with triparanol (MER-29).
    Sachs BA; Wolfman L
    Am J Clin Nutr; 1961; 9():760-3. PubMed ID: 14495832
    [No Abstract]   [Full Text] [Related]  

  • 18. MER-29 (triparanol) in the control of hypercholesterolaemia.
    JEPSON EM
    Proc R Soc Med; 1962 Jun; 55(6):480-4. PubMed ID: 14451692
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of MER-29 on the intermediary metabolism of cholesterol.
    FRANTZ ID; MOBBERLEY ML; SCHROEPFER GJ
    Prog Cardiovasc Dis; 1960 May; 2():511-8. PubMed ID: 13824600
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of hypercholesterolemia by interference with cholesterol biosynthesis using MER-29.
    LECKERT JT; MCHARDY G; MCHARDY R; WELCH GE; CRADIC H
    J La State Med Soc; 1960 Jul; 112():259-65. PubMed ID: 14415072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.